Related Experiment Video
Updated: Jul 11, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
A plain language summary of how some fungi samples that show resistance to antifungal medicines have changes in their
Mariana Castanheira1, Timothy D Collingsworth1, Andrew P Davis1
1JMI Laboratories, North Liberty, Iowa, United States of America.
What Is This Summary About?:
Aspergillus fumigatus (shortened to A. fumigatus) is a fungus (plural: fungi) that can cause a serious infection in some people. A. fumigatus can become resistant to medicines known as azoles (isavuconazole, itraconazole, posaconazole, and voriconazole). This means they stop working and are not able to kill the fungus. Fungi can become resistant through changes in their genes, which are called mutations. Scientists looked at previously collected samples from people infected with A. fumigatus and found that 36 of the samples showed resistance to an azole. In 35 of these samples, scientists looked for mutations in 50 genes. These 50 genes are known to play a role in azole resistance and/or are important for fungal survival.
What Were The Results?:
In total, 18 out of 36 samples (50%) showed resistance to isavuconazole only. Of these, 12 had mutations in 4 genes important for fungal survival (called erg3C, erg2, erg7B and erg4B). Mutations were found in 2 genes that are the most common causes of azole resistance (called cyp51A and cyp51B). The most common mutation, called cyp51A TR34/L98H, was found in 9 samples. Of these, 8 samples showed resistance to all 4 of the azoles tested.
What Do The Results Of The Study Mean?:
Studying mutations that make fungi resistant to medicines helps to make sure that people with fungal infections get treated with medicines that will work for them.
Insights
Fungal infections caused by Aspergillus fumigatus are becoming resistant to azole medicines. Gene mutations are responsible for this resistance, impacting treatment effectiveness for patients.
Area of Science:
- Medical Mycology
- Antifungal Resistance
- Molecular Biology
Background:
- Aspergillus fumigatus (A. fumigatus) is a fungus causing serious infections.
- Azole antifungal drugs (isavuconazole, itraconazole, posaconazole, voriconazole) are used to treat these infections.
- Fungal resistance to azoles is a growing concern, driven by genetic mutations.
Purpose of the Study:
- To investigate genetic mutations associated with azole resistance in Aspergillus fumigatus.
- To identify specific genes and mutations conferring resistance to azole antifungals.
Main Methods:
- Analysis of previously collected clinical samples from A. fumigatus infections.
- Screening 36 azole-resistant samples for mutations in 50 key genes.
- Sequencing targeted genes to identify specific resistance mechanisms.
Main Results:
- 50% (18/36) of samples showed resistance to isavuconazole.
- Mutations in survival genes (erg3C, erg2, erg7B, erg4B) were found in 12 isavuconazole-resistant samples.
- The common cyp51A TR34/L98H mutation was identified in 9 samples, with 8 showing resistance to all tested azoles.
Conclusions:
- Genetic mutations, particularly in cyp51A, are significant drivers of azole resistance in A. fumigatus.
- Understanding these mutations is crucial for effective antifungal treatment strategies.
- Continued surveillance of antifungal resistance mechanisms is essential for public health.
Related Concept Videos
Development of Antibiotic Resistance
Treatment Resistant Cancers
Antibiotic Selection
Overview of Fungi
Mutations in Microorganisms
Gene Regulation in Microbial Communities: Quorum Sensing

